Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to obtain data about changing from the chlorofluorocarbon (CFC) - containing Berotec®
200 µg metered - dose inhaler to the CFC - free Berotec® N 100 µg metered - dose inhaler